Yasuhito Tanaka

97PUBLICATIONS
329CO-AUTHORS
Predictive and prognostic markersElectrometallurgyChemotherapyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Jul 26, 2026
Letter: Interpretation of Cognitive and Clinical Outcomes in the Randomized Trial of Rifaximin for Covert Hepatic Encephalopathy. Authors' Reply.

|Jul 23, 2026
Chelate-conjugated β-lactams resensitize metallo-β-lactamase IMP-1-producing gram-negative bacteria against carbapenem antibiotics.

|Jul 21, 2026
Direct-Acting Antiviral Therapy and Hepatocellular Carcinoma in Captive Chimpanzees With Long-Standing Chronic Hepatitis C Virus Infection.

|Jul 15, 2026
HER2-positive rectal adenocarcinoma metastatic to the pancreas complicated by obstructive pancreatitis and an infected pseudocyst: a case report.

|Jul 13, 2026
Editorial: Rifaximin and the Gut-Liver-Brain Axis-Progress and Prudence. Authors' Reply.

|Jul 06, 2026
Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab.

Pageof 17

Frequent Collaborators

11 joint publications

Hidenori Toyoda

11 joint publications

Katsuya Nagaoka

10 joint publications

Hiroki Inada

8 joint publications

Toru Ishikawa